A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxyg
The goal of the study is to explore the efficacy and safety of hyperbaric oxygen in the neoadjuvant treatment of breast cancer patients
| Condition(s) | Breast Cancers |
|---|---|
| Status | Recruiting |
| Phase | Phase 1, Phase 2 |
| Study type | Interventional |
| Summary | The goal of the study is to explore the efficacy and safety of hyperbaric oxygen in the neoadjuvant treatment of breast cancer patients |
| Who can participate | Inclusion Criteria: 1. Understand the study process, participate in the study voluntarily, and sign the informed consent form. 2. patients with histopathologically confirmed initial unilateral primary invasive breast cancer, occult breast cancer, Patients with histopathologically confirmed initial unilateral primary invasive breast cancer, with the exception of occult breast cancer, inflammatory breast cancer and eczema-like carcinoma 3. aged ≥ 18 years and ≤ 60 years, female 4. patients who meet the inclusion criteria for neoadjuvant therapy to receive neoadjuvant therapy for breast cancer (locally advanced) Patients with locally advanced breast cancer (AJCC stage III, except T3N1M0) or operable breast cancer, but without breast-conserving or axillary preservation (stage IIA-IIB and T3N1M |
| Ages | 18 Years to 60 Years |
| Sex | Female |
| Lead sponsor | Guangdong Provincial People's Hospital |
| Locations | Guangzhou, Guangdong, China; Shantou, Guangdong, China |
| Start date | 2025-02-01 |
| NCT ID | NCT06811870 |
| Official listing | https://clinicaltrials.gov/study/NCT06811870 |